Global Neurostimulation Devices Market Size, Share, Opportunities, And Trends By Type (Spinal Cord Stimulation Device, Deep Nerve Stimulation Device, Vagus Nerve Stimulation Device, Sacral Nerve Stimulation Device), By Application (Pain Management, Sleep Apnea, Cochlear Implants, Neurology), By End-Users (Hospitals & Clinics, Ambulatory Care Centers), And By Geography - Forecasts From 2025 To 2030

Neurostimulation Devices Market Size:

Global Neurostimulation Devices Market is projected to grow at a CAGR of 8.57% between 2025 to 2030.

Neurostimulation devices are implantable, programmable medical devices that deliver electrical stimulation to specific parts of the patient's brain, spinal cord, or peripheral nervous system for the treatment of various conditions such as chronic pain, movement disorders, epilepsy, and Parkinson's disease. Neurostimulation is used as a key element in neural prosthetics for hearing aids, artificial vision, artificial limbs, brain-machine interfaces, etc.

Neurostimulation Devices Market Trends:

The growth in the neurostimulation devices market may be attributed to the increasing prevalence of chronic neuromuscular disorders and the rising adoption of these devices by physicians. Recent advances in neurotechnologies and neuroimaging have resulted in a rapid rise in the use of neurostimulation devices for the treatment of an increasingly wide range of neurologic and psychiatric disorders, thus leading to the robust growth of the market for the given forecast period.

However, stringent regulations of neurostimulation devices and a lack of skilled professionals for performing the surgeries might restrain the market growth during the given time frame. With the increasing investments in the development of novel and advanced neurostimulation devices, the market is expected to surge at an exponential rate during the forecast period.

Neurostimulation Devices Market Growth Drivers:

• Hearing Loss and deafness.

The market is expected to surge in the coming years, due to the rise in the number of people suffering from hearing loss and other related concerns. According to the data given by the World Health Organisation, approximately. 2.5 billion people are expected to have some sort of hearing loss, and an estimated 700 million will require hearing rehabilitation by the year 2050. There has been an urge in the need for advanced and safer hearing loss devices and solutions. More than 1 billion young adults are at high risk of avoidable, permanent hearing loss due to unsafe listening practices and a lack of availability of high-quality devices and solutions.

Major companies and organizations have been providing high-quality neurostimulation devices for their customers. Cochlear implants are expected to generate significant demand in the coming years. For instance, Cochlear, one of the major players in the market, has been providing implantable hearing solutions for decades. These developments are expected to have a positive impact on the market in the coming years.

In June 2021, Oticon Medical, one of the key players in the market, announced that the United States Food and Drug Administration had granted and provided premarket approval to the firm's Neuro System to treat and cure individuals 18 years or above. The firm had been intended to treat patients with bilateral severe-to-profound sensorineural hearing loss. This system is known as the Neuro Cochlear Implant System.

• Increasing Geriatric Population

The market is expected to surge in the coming years, due to the increasing geriatric population globally. According to the data given by the United Nations, there were an estimated 703 million people who were aged 65 years or over in 2019. The UN report also stated that the number of older people, globally, is expected to double to an estimated 1.5 million in the year 2050. An aging population is expected to put significant financial pressure on old-age support systems.

Older people tend to suffer from chronic pain, spinal cord pain, nerve pain, and hearing loss. With the rise in the development of novel and advanced neurostimulator devices and systems, the demand for their use for older people is expected to surge. According to several official studies conducted, there has been an improvement in hearing capabilities with the use of cochlear implants in older people. This development is expected to enhance market growth in the coming years.

Neurostimulation Devices Market Segmentation:

• By Type
  • Spinal Cord Stimulation Device
  • Deep Nerve Stimulation Device
  • Vagus Nerve Stimulation Device
  • Sacral Nerve Stimulation Device
• By Application
  • Pain Management
  • Sleep Apnea
  • Cochlear Implants
  • Neurology
• By End-User
  • Hospitals & Clinics
  • Ambulatory Care Centers
• By Geography
  • North America
    • USA
    • Canadá
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Others
  • Middle East and Africa
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Thailand
    • Taiwan
    • Indonesia
    • Others

INNOPSYS

Abbott

Synergia Medical

Medtronic

Stimwave LLC

Boston Scientific

LivaNova

NeuroSigma

Axonics

Neuronetics